Abstract
Leishmaniasis has been ignored for many years mainly because it plagues remote and poor areas. However, recently, it has drawn attention of several investigators, and active research is going on for antileishmanial drug discovery. The current available drugs have high failure rates and significant side effects. Recently, liposomal preparations of amphotericin B are available and have proved to be a better drug, but they are very expensive. Miltefosine is one of the few orally administered drugs that are effective against Leishmania. However, it has exhibited teratogenicity, hence, should not be administered to pregnant women. Thus, the search for novel and improved antileishmanial drugs continue. A rational approach to design and develop new antileishmanials can be to identify several metabolic and biochemical differences between host and parasite that can be exploited as drug target. Moreover, many natural products also have significant antileishmanial activity and are yet to be exploited. In the current review, we aim to bring together various drug targets of Leishmania, recent development in the field, future prospects, and hope in the area.
Similar content being viewed by others
References
Myler, P. J. & Fasel, N. (2008). Leishmania: after the genome. Wymondham, UK: Caister Academic Press.
Alvar, J. Yactayo, S. & Bren, C. (2006). Trends in Parasitology, 2, 552–557.
Murray, H. W. (2002). New England Journal of Medicine, 347, 1793–1794.
Bora, D. (1999). National Medical Journal of India, 12, 62–68.
Dujardin, J. C. Campino, L. Canavate, C. et al. (2008). Europe. Emerging Infectious Diseases, 14, 1013–1018.
Slappendel, R.J., & Ferrer, L. (1998). In: C. E. Greene (Ed.), Infectious diseases of the dog and cat (pp. 450–458). Philadelphia: WB Saunders Co.
Grosjean, N. L. Vrable, R. A. Murphy, A. J. & Mansfield, L. S. (2003). Journal of the American Veterinary Medical Association, 222, 603–606.
Croft, S. L. & Coombs, G. H. (2003). Trends in Parasitology, 19, 502–508.
Pearson, R. D. Jeronimo, S. M. B. & Sousa, A. (1996). Clinical Infectious Diseases, 22, 1–13.
Mattock, N. (1999). TDR News, 60, 1–2.
Sinha, P. K. Ranjan, A. Singh, V. P. Das, V. N. R. Pandey, K. Kumar, N. et al. (2006). Journal of Infection, 53, 60–64.
Berman, J. (2003). Current Opinion in Infectious Diseases, 16, 397.
Sundar, S. Jha, T. K. Thakur, C. P. Sinha, P. K. & Bhattacharya, S. K. (2007). New England Journal of Medicine, 356, 2571–2581.
Dumas, C. Ouellette, M. Tovar, J. Cunningham, M. J. Fairlamb, A. H. Tamar, S. et al. (1997). EMBO Journal, 16, 2590–2598.
Flohe, L. Hecht, H. J. & Steinert, P. (1999). Free Radical Biology & Medicine, 27, 966–984.
Alphey, M. S. Bond, C. S. Tataud, E. Fairlamb, A. H. & Hunter, W. N. (2000). Journal of Molecular Biology, 300, 903–916.
Bonse, S. Santelli-Rouvier, C. Barbe, J. et al. (1999). Journal of Medicinal Chemistry, 42, 5448–5454.
Parveen, S. Khan, M. O. F. Austin, S. E. Croft, S. L. Yardley, V. Rock, P. et al. (2005). Journal of Medicinal Chemistry, 48, 8087–8097.
Fournet, A. Barrios, A. A. Munoz, V. Hocquemiller, R. Cave, A. & Bruneton, J. (1993). Antimicrobial Agents and Chemotherapy, 37, 859–863.
Meiering, S. Inhoff, O. Mies, J. Vincek, A. Garcia, G. Kramer, B. et al. (2005). Journal of Medicinal Chemistry, 48, 4793–4802.
Thronalley, P. J. Ladan, M. J. Ridgway, S. J. S. & Kang, Y. (1996). Journal of Medicinal Chemistry, 39, 3409–3411.
Vickers, T. J. Greig, N. & Fairlamb, A. H. (2004). Proceedings of the National Academy of Sciences of the United States of America, 101, 13186–13191.
Bringaud, F. Rivière, L. & Coustou, V. (2006). Molecular and Biochemical Parasitology, 149, 1–9.
Haanstra, J. R. Tuil, A. V. Kesseler, P. Reijnders, W. Michels, P. A. M. Westerhoff, H. V. et al. (2008). Proceedings of the National Academy of Sciences of the United States of America, 105(46), 17718–17723.
Michels, P. A. M. Bringaud, F. Herman, M. Hannaert, M. & Hannaert, V. (2006). Biochimica et Biophysica Acta, 1763, 1463–1477.
Datta, A. K. Datta, R. & Sen, B. (2008). Antiparasitic chemotherapy: tinkering with the purine salvage pathway. Advances in Experimental Medicine and Biology, 625, 116–132.
Aronow, B. Kaur, K. McCartan, K. & Ullman, B. (1987). Molecular and Biochemical Parasitology, 22, 29–37.
Glew, R. H. Saha, A. K. Das, S. & Remaley, A. (1988). Microbiological Reviews, 52(4), 412–432.
Lafon, S. W. Nelson, D. J. Berens, R. L. & Marr, J. J. (1985). Journal of Biological Chemistry, 260(17), 9660–9665.
Chen, M. Zhai, L. Christensen, S. B. Theander, T. G. & Kharazmi, A. (2001). Antimicrobial Agents and Chemotherapy, 45, 2023–2029.
Torres-Santos, E. C. Sampaio-Santos, M. I. Buckner, F. S. Yokoyama, K. Gelb, M. Urbina, J. A. et al. (2009). Journal of Antimicrobial Chemotherapy, 63, 469–472.
Salem, M. M. & Werbovetz, K. A. (2005). Antiprotozoal Compounds from Psorothamnus polydenius. Journal of Natural Products, 68, 108.
Delorenzi, J. C. Attias, M. Gattass, C. R. Andrade, M. Rezende, C. da Cunha Pinto, A. et al. (2001). Antimicrobial Agents and Chemotherapy, 45, 1349–1354.
Saleheen, D. Ali, S. A. & Yasinzai, M. M. (2004). Fitoterapia, 75, 9–13.
Ngure, P. K. Tonui, W. K. Ingonga, J. Mutai, C. Kigondu, E. Nganga, Z. et al. (2009). Journal of Medicinal Plants Research, 3, 61–66.
Singh, N. Mishra, P. K. Kapil, A. Arya, K. R. Maurya, R. & Dube, A. (2005). Journal of Ethnopharmacology, 98, 83–88.
Misra, P. Khaliq, T. Reddy, K. P. Gupta, S. Kant, R. Maulik, P. R. et al. (2008). Journal of Antimicrobial Chemotherapy, 62, 998–1002.
Chowdhury, A. R. Mandal, S. Mittra, B. Sharma, S. Mukhopadhyay, S. & Majumder, H. K. (2002). Medical Science Monitor, 8, BR254–BR265.
Chowdhury, A. R. Sharma, S. Mandal, S. Goswami, A. Mukhopadhyay, S. & Majumder, H. K. (2002). Biochemical Journal, 366(Pt 2), 653–661.
Roy, A. Ganguly, A. BoseDasgupta, S. Das, B. B. Pal, C. Jaisankar, P. et al. (2008). Molecular Pharmacology, 74, 1292–1307.
Singh, B. K. Sarkar, N. & Dubey, V. K. (2008). Current Trends in Biotechnology and Pharmacy, 2, 390–395.
Singh, B. K. Sarkar, N. Jagannadham, M. V. & Dubey, V. K. (2008). BMB Reports, 41, 444–447.
Akendengue, B. Roblot, F. Loiseau, P. M. Bories, C. Ngou-Milama, E. Laurens, A. et al. (2002). Phytochemistry, 59, 885.
Fevrier, A. Ferreira, M. E. Fournet, A. Yaluff, G. Inchausti, A. Rojas de Arias, A. et al. (1999). Planta Medica, 65, 47.
Marles, R. J. Farnsworth, N. R. & Neill, D. A. (1989). Journal of Natural Products, 52, 261.
Hoet, S. Stevigny, C. Block, S. Opperdoes, F. Colson, P. Baldeyrou, B. et al. (2004). Planta Medica, 70, 407.
Moretti, C. Sauvain, M. Lavaud, C. Massiot, G. Bravo, J. & Munoz, V. (1998). Journal of Natural Products, 61, 1390.
Fournet, A. De Arias, R. A. Ferreira, M. E. et al. (2000). International Journal of Antimicrobial Agents, 13, 189–195.
Thouvenel, C. Hocquemiller, R. & Fournet, A. (2002). Journal of Ethnopharmacology, 80, 199–202.
Ray, S. Hazra, B. Mittra, B. Das, A. & Majumder, H. K. (1998). Molecular Pharmacology, 54, 994.
Camacho, M. R. Kirby, G. C. Warhurst, D. C. Croft, S. L. & Phillipson, J. D. (2002). Planta Medica, 66, 478.
Montenegro, H. Gutierrez, M. Romero, L. I. Ortega-Barria, E. Capson, T. L. & Rios, L. C. (2003). Planta Medica, 69, 677.
Kalla, G. Singh, M. K. & Kalla, G. (1996). Indian Journal of Dermatology Venereology and Leprology, 62, 149–151.
El-On, J. Jacobs, G. P. Witztum, E. & Greenblatt, C. L. (1984). Antimicrobial Agents and Chemotherapy, 26, 745. district.
Takahashi, M. Fuchino, H. Satake, M. Agatsuma, Y. & Sekita, S. (2004). Biological and Pharmaceutical Bulletin, 27, 921.
Del Rayo Camacho, M. Phillipson, J. D. Croft, S. L. Yardley, V. & Solis, P. N. (2004). Planta Medica, 70, 70.
Mbwambo, Z. H. Apers, S. Moshi, M. J. Kapingu, M. C. VanMiert, S. Claeys, M. et al. (2004). Planta Medica, 70, 706.
Plock, A. Beyer, G. Hiller, K. Grundemann, E. Krause, E. Nimtz, M. et al. (2001). Phytochemistry, 57, 489.
Saeidnia, S. Gohari, A. R. Uchiyama, N. Ito, M. Honda, G. & Kiuchi, F. (2004). Chemical and Pharmaceutical Bulletin, 52, 1249.
Thiem, D. A. Sneden, A. T. Khan, S. I. & Tekwani, B. L. (2005). Journal of Natural Products, 68, 251.
Muhammad, I. Bedir, E. Khan, S. I. Tekwani, B. L. Khan, I. A. Takamatsu, S. et al. (2004). Journal of Natural Products, 67, 772.
Singh, N. Gupta, R. Jaiswal, A. K. Sundar, S. & Dube, A. (2009). Journal of Antimicrobial Chemotherapy, 64(2), 370–374. doi:10.1093/jac/dkp206.
Khan, M. (2007). Drug Target Insights, 1, 129–146.
Benson, T. J. Mckie, J. H. Garforth, J. Borges, A. Fairlamb, A. H. & Douglas, K. T. (2008). Journal of Biochemistry, 286, 9–11.
Cota, B. B. Rosa, L. H. Caligiorne, R. B. Rabello, A. L. T. Almeida Alves, T. M. & Zani, C. S. (2008). FEMS Microbiology Letters, 285, 177–182.
Heby, O. Roberts, S. C. & Ulman, B. (2005). Biochemical Society Transactions, 31, 415–419.
Bhaumik, S. Basu, R. Sen, S. Naskar, K. & Roy, S. (2008). Vaccine, 12, 053.
Delfin, D. A. Morgan, E. R. Zhu, X. & Werbovetz, A. K. (2009). Bioorganic & Medicinal Chemistry, 17, 820–829.
Acknowledgement
Infrastructural facilities provided by Indian Institute of Technology Guwahati and Financial support by Department of Biotechnology (Project No.: SAN No. 102/IFD/SAN/PR1827/2008-2009) and Department of Information Technology (Project No.: DIT/R&D/BIO/15(12)/2008), Government of India, in the form of research grant to VKD are acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shukla, A.K., Singh, B.K., Patra, S. et al. Rational Approaches for Drug Designing Against Leishmaniasis. Appl Biochem Biotechnol 160, 2208–2218 (2010). https://doi.org/10.1007/s12010-009-8764-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-009-8764-z